Overall rank by patents
#43,782
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, active 2019–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Uneeg holds 6 US patents across 3 technology areas, rank #43,782 of 50,000 tracked assignees.
Uneeg Medical A/s has been granted 6 US utility patents between 2019 and 2024, placing Uneeg Medical A/s at rank #43,782 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 4.2 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Uneeg Medical A/s is one of the more focused assignees in the PatentsView dataset. By volume, Uneeg sits between Ultratech International, Inc. (6 patents, rank #43,778) and Uniquify IP Company, Llc (6 patents, rank #43,786) - the closest US assignees by grant volume. The composite Innovation Score of 35.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 1 in the 2015–2019 window, a +400% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Uneeg Medical A/s's 4.2 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Uneeg Medical A/s against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ULTRATECH INTERNATIONAL, INC.
6 patents
UMAMI WORLDWIDE, LLC
6 patents
UMBRAGROUP S.P.A.
6 patents
UMF Corporation
6 patents
UNICREDIT S.p.A.
6 patents
UNIL ELECTRONICS CORPORATION
6 patents
UNION ENGINEERING A/S
6 patents
UNIQUIFY IP COMPANY, LLC
6 patents
UNEEG medical A/S
6 patents
What this shows Uneeg holds 6 patents at rank #43,782, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #43,782 in granted patent volume.
Other assignees with the most granted patents in Uneeg's primary technology class.
Uneeg's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 16.7% |
| 2024 | 5 | 83.3% |
Top 3 of 3 technology areas
Overall rank by patents
#43,782
Across all tracked assignees
35.4 out of 100
How to use this portfolio
Uneeg's 6 grants land it in the top 50% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.